Stem cell researchers at the Lund University, Germany, identify ZNF558, a transcription factor expressed in human but not chimpanzee forebrain progenitors cells, that regulates mitochondrial function and determines the timing of early human brain development. The authors show this transcription factor regulates a gene called SPATA18 that regulates the selective degradation of mitochondria. The expression of ZNF558 is controlled by the size of a structural repeat in noncoding DNA that is longer in chimpanzees than in humans. The study provides evidence of a role for DNA structural variations in human brain evolution and may contribute to genetics-based answers to questions about psychiatric disorders that are unique to humans.
Scientists have identified a new multi-kinase inhibitor that targets breast cancer stem cells in chemotherapy-resistant triple negative breast cancer. TNBC disproportionately affects younger, premenopausal women, women with inherited mutations in the BRCA1 gene, and Black women. The new therapy holds the potential to improve survival and quality of life for patients diagnosed with triple negative breast cancer who are currently treated with a combination of radiation and chemotherapy that is largely ineffective.
A new type of intermediate-stage stem cell, isolated from mice, horses and humans, is endowed with the unique dual potency of being able to form inter- and intra-species chimeras, and to generate precursors of sperm and ova.